Cleared Traditional

K960056 - USCI PRO FLO XT,SOFT TIP, AND XT SOFT TIP ANGIOGRAPHIC

K960056 is an FDA 510(k) clearance for USCI PRO FLO XT, manufactured by C.R. Bard, Inc.. The device is a Class 2 Cardiovascular device with product code DQO cleared through the Traditional 510(k) pathway after a 293-day FDA review.

K960056 · C.R. Bard, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1996
Decision
293d
Days
Class 2
Risk

K960056 is an FDA 510(k) clearance for the USCI PRO FLO XT,SOFT TIP, AND XT SOFT TIP ANGIOGRAPHIC. Classified as Catheter, Intravascular, Diagnostic (product code DQO), Class II - Special Controls.

Submitted by C.R. Bard, Inc. (Billerica, US). The FDA issued a Cleared decision on October 23, 1996 after a review of 293 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1200 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all C.R. Bard, Inc. devices

FDA 510(k) Submission Details - K960056

510(k) Number K960056 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 04, 1996
Decision Date October 23, 1996
Days to Decision 293 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
168d slower than avg
Panel avg: 125d · This submission: 293d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQO Device Classification - Class 2, Special Controls

Product Code DQO Catheter, Intravascular, Diagnostic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1200
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQO Catheter, Intravascular, Diagnostic

All 403
Devices cleared under the same product code (DQO) and FDA review panel - the closest regulatory comparables to K960056.
SCIMED 5 FRENCH IMPULSE ANGIOGRAPHIC CATHETERS
K964859 · Scimed Life Systems, Inc. · Feb 1997
MAXI-TORQUE PLUS SOFTIP ANGIOGRAPHIC CATHETER
K963092 · Adam Spencer Corp. · Jan 1997
ASC HIGH PRESSURE BRAIDED TUBES
K964331 · Adam Spencer Corp. · Jan 1997
LAGUNA SOFTIP DIAGNOSTIC CATHETERS
K961499 · Boston Scientific Scimed, Inc. · Oct 1996
SPYGLASS ANGIOGRAPHIC CATHETER
K962805 · Daig Corp. · Oct 1996
4F NYLEX ANGIOGRAPHIC CATHETER
K962759 · Cordis Corp. · Oct 1996